ARCHIVES

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

Center Core Grants Picture Less Bleak; Competing Renewals To Receive 50% Of Recommended Increases

January 4, 1980

In Brief: NCI Reorganization Announcement Coming Up; No Decisions On Organ Site, Center Programs NCI Reorganization

May 12, 1978

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

Protocols Approved By NCI

April 30, 2004